It was reported that ACE2 decreased the VEGFa expression of breast cancer cells, inhibiting phosphorylation of ERK1/2, suggesting that ERK signaling pathway mediated by ACE2 participated in the regulation of VEGFa [25]. This evidence concerns the gene ACE2 and breast carcinoma.